Chemotherapy: YES or NO?

The FEMTELLE® uPA/PAI-1 Test helps to make informed treatment decisions

The FEMTELLE® uPA/PAI-1 Assay is included in German and American guidelines. The test helps to assess risk of disease recurrence in primary breast cancer and predicts chemotherapy benefit after breast cancer surgery.

The  FEMTELLE® uPA/PAI-1 Assay indicates if chemotherapy is, in fact necessary and helps to predict chemotherapy benefit after surgery.

News

FEMTELLE Brochure

A new revised version of our FEMTELLE Brochure is now available. more...

Terms of Use:
The information on this website is for your personal information only and may not be used as a substitute for personal professional advice or treatment by trained and licensed physicians. The content of this page may not be used to make unauthorized diagnoses or initiate treatments.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close